Watch Ticker

Bright Minds Biosciences Inc. Common Stock

Go to Bright Minds Biosciences Inc. Common Stock Website

$35.59

0.18 (0.51%)

Live

Previous Close

$35.59

Day Range

$33.96 - $35.95

Previous Day Range

$34.4 - $36.72

Market Cap

$250.8 million USD

Day Vol.

30984

Previous Day Vol.

39578

Currency

USD

Primary Exchange

Nasdaq

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience, a Nasdaq-listed AI company, announced its Q3 2024 financial results and provided updates on its partnerships with pharmaceutical companies like Bright Minds Bioscience, Novartis, and Takeda to advance its Brain Network Analytics (BNA) technology for neurological and mental disorder treatments.

Related tickers: AIFF, DRUG, NVS, TAK.

Read Full Article

N/A - Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Bright Minds Biosciences Inc. has closed a $35 million private placement, with participation from several healthcare investors. The company plans to use the proceeds for research and development related to its drug development programs.

Related tickers: DRUG.

Read Full Article

Trending Tickers

Please sign in to view